Presentation is loading. Please wait.

Presentation is loading. Please wait.

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment  M. Driesen, Y. Kondo, B.C. de.

Published byLanny Yuwono Modified over 5 years ago

Similar presentations

Presentation on theme: "Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment  M. Driesen, Y. Kondo, B.C. de."— Presentation transcript:

1 Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment  M. Driesen, Y. Kondo, B.C. de Jong, G. Torrea, S. Asnong, C. Desmaretz, K.S.M. Mostofa, S. Tahseen, M.G. Whitfield, D.M. Cirillo, P. Miotto, A.M. Cabibbe, L. Rigouts  Clinical Microbiology and Infection  Volume 24, Issue 1, Pages (January 2018) DOI: /j.cmi Copyright © 2017 The Authors Terms and Conditions

2 Clinical Microbiology and Infection 2018 24, 60-64DOI: (10.1016/j.cmi.2017.05.026)
Copyright © 2017 The Authors Terms and Conditions

3 Clinical Microbiology and Infection 2018 24, 60-64DOI: (10.1016/j.cmi.2017.05.026)
Copyright © 2017 The Authors Terms and Conditions

Download ppt "Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment  M. Driesen, Y. Kondo, B.C. de."

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages 19-23.

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay  V.A.T. Nguyen, H.Q. Nguyen,

Reduced turn-around time for Mycobacterium tuberculosis drug susceptibility testing with a proportional agar microplate assay  V.A.T. Nguyen, H.Q. Nguyen,
Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates 

Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates 
Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster- randomized controlled trial  P.J. van der Geest, M. Mohseni, D. Nieboer,

Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster- randomized controlled trial  P.J. van der Geest, M. Mohseni, D. Nieboer,
Cryptococcosis—the impact of delay to diagnosis

Cryptococcosis—the impact of delay to diagnosis
Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan  H. Ando, S. Mitarai, Y. Kondo, T. Suetake, J.-I. Sekiguchi,

Pyrazinamide resistance in multidrug-resistant Mycobacterium tuberculosis isolates in Japan  H. Ando, S. Mitarai, Y. Kondo, T. Suetake, J.-I. Sekiguchi,
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,

Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review  D. Papaventsis, N. Casali, I. Kontsevaya,

Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review  D. Papaventsis, N. Casali, I. Kontsevaya,
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
I.J. Schalk  Clinical Microbiology and Infection 

I.J. Schalk  Clinical Microbiology and Infection 
Salvage therapy for multidrug-resistant tuberculosis

Salvage therapy for multidrug-resistant tuberculosis
Approach to diagnosis of infective endocarditis

Approach to diagnosis of infective endocarditis
Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in.

Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in.
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 

D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Migrant health—a cause for concern?

Migrant health—a cause for concern?
Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by.

Novel rapid PCR for the detection of Ile491Phe rpoB mutation of Mycobacterium tuberculosis, a rifampicin-resistance-conferring mutation undetected by.
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.

Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
Refugee crisis and re-emergence of forgotten infections in Europe

Refugee crisis and re-emergence of forgotten infections in Europe

Similar presentations

Ads by Google